Results
|
|
1341.
|
Novel mechanism of lapatinib resistance in HER2-positive breast tumor cells: activation of AXL. [electronic resource] by
- Liu, Li
- Greger, James
- Shi, Hong
- Liu, Yuan
- Greshock, Joel
- Annan, Roland
- Halsey, Wendy
- Sathe, Ganesh M
- Martin, Anne-Marie
- Gilmer, Tona M
Producer: 20091117
In:
Cancer research vol. 69
Availability: No items available.
|
|
|
1342.
|
Current standards in the treatment of metastatic breast cancer with focus on Lapatinib: a review by a Central European Consensus Panel. [electronic resource] by
- Steger, Guenther G
- Abrahámová, Jitka
- Bacanu, Florin
- Brincat, Stephen
- Brize, Arija
- Cesas, Alvydas
- Cufer, Tanja
- Dank, Magdolna
- Duchnowska, Renata
- Eniu, Alexandru
- Jassem, Jacek
- Kahán, Zsuzsanna
- Matos, Erika
- Padrik, Peeter
- Plāte, Signe
- Pokker, Helis
- Purkalne, Gunta
- Timcheva, Constanta
- Tzekova, Valentina
- Vyzula, Rostislav
- Zielinski, Christoph C
Producer: 20101122
In:
Wiener klinische Wochenschrift vol. 122
Availability: No items available.
|
|
|
1343.
|
|
|
|
1344.
|
Trastuzumab emtansine for HER2-positive advanced breast cancer. [electronic resource] by
- Verma, Sunil
- Miles, David
- Gianni, Luca
- Krop, Ian E
- Welslau, Manfred
- Baselga, José
- Pegram, Mark
- Oh, Do-Youn
- Diéras, Véronique
- Guardino, Ellie
- Fang, Liang
- Lu, Michael W
- Olsen, Steven
- Blackwell, Kim
Producer: 20121119
In:
The New England journal of medicine vol. 367
Availability: No items available.
|
|
|
1345.
|
|
|
|
1346.
|
|
|
|
1347.
|
|
|
|
1348.
|
|
|
|
1349.
|
Safety and efficacy of neratinib in combination with capecitabine in patients with metastatic human epidermal growth factor receptor 2-positive breast cancer. [electronic resource] by
- Saura, Cristina
- Garcia-Saenz, Jose A
- Xu, Binghe
- Harb, Wael
- Moroose, Rebecca
- Pluard, Timothy
- Cortés, Javier
- Kiger, Corinne
- Germa, Caroline
- Wang, Kongming
- Martin, Miguel
- Baselga, José
- Kim, Sung-Bae
Producer: 20150320
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 32
Availability: No items available.
|
|
|
1350.
|
|
|
|
1351.
|
|
|
|
1352.
|
Dual inhibition of MEK1/2 and EGFR synergistically induces caspase-3-dependent apoptosis in EGFR inhibitor-resistant lung cancer cells via BIM upregulation. [electronic resource] by
- Song, Ji-Young
- Kim, Choung-Soo
- Lee, Je-Hwan
- Jang, Se Jin
- Lee, Sang-wook
- Hwang, Jung Jin
- Lim, Chulsoo
- Lee, Gilnam
- Seo, Jeongbeob
- Cho, Suk Young
- Choi, Jene
Producer: 20140708
In:
Investigational new drugs vol. 31
Availability: No items available.
|
|
|
1353.
|
|
|
|
1354.
|
|
|
|
1355.
|
Up-Regulation of Transient Receptor Potential Melastatin 6 Channel Expression by Tumor Necrosis Factor-α in the Presence of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor. [electronic resource] by
- Furukawa, Chisa
- Fujii, Naoko
- Manabe, Aya
- Matsunaga, Toshiyuki
- Endo, Satoshi
- Hasegawa, Hajime
- Ito, Yoshinori
- Yamaguchi, Masahiko
- Yamazaki, Yasuhiro
- Ikari, Akira
Producer: 20170919
In:
Journal of cellular physiology vol. 232
Availability: No items available.
|
|
|
1356.
|
|
|
|
1357.
|
Real-World Data of Pyrotinib-Based Therapy in Metastatic HER2-Positive Breast Cancer: Promising Efficacy in Lapatinib-Treated Patients and in Brain Metastasis. [electronic resource] by
- Lin, Ying
- Lin, Mingxi
- Zhang, Jian
- Wang, Biyun
- Tao, Zhonghua
- Du, Yiqun
- Zhang, Sheng
- Cao, Jun
- Wang, Leiping
- Hu, Xichun
Producer: 20210621
In:
Cancer research and treatment vol. 52
Availability: No items available.
|
|
|
1358.
|
|
|
|
1359.
|
|
|
|
1360.
|
|